- Thursday, September 28, 2023
8:00 AM – 8:15 AM ET
Welcome
8:00 AM – 8:15 AM ET
WelcomeCo-Chair: – Vanderbilt-Ingram Cancer Center
Co-Chair: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Co-Chair###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Co-Chair: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Co-Chair###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Co-Chair: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### 8:15 AM – 8:30 AM ET
1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Neoadjuvant Immunotherapy
8:15 AM – 8:30 AM ET
Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Neoadjuvant ImmunotherapyPresenter: – Memorial Sloan Kettering Cancer Center
Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center ### 1003985###Presenter###Chief, Gastrointestinal Oncology Service###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
###
8:30 AM – 8:45 AM ET
1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Adjuvant Immunotherapy
8:30 AM – 8:45 AM ET
Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Adjuvant ImmunotherapyPresenter: – Kansas University Cancer Center
Anup Kasi, MD, MPH – Kansas University Cancer Center ### 1919511###Presenter###Associate Professor###Kansas University Cancer Center###Presenter: – Kansas University Cancer Center
###
8:45 AM – 9:00 AM ET
1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers
8:45 AM – 9:00 AM ET
Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - DiscussionModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – Memorial Sloan Kettering Cancer Center
Panelist: – Kansas University Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center ### 1003985###Panelist###Chief, Gastrointestinal Oncology Service###Memorial Sloan Kettering Cancer Center###Panelist: – Memorial Sloan Kettering Cancer Center
### @@@ Anup Kasi, MD, MPH – Kansas University Cancer Center ### 1919511###Panelist###Associate Professor###Kansas University Cancer Center###Panelist: – Kansas University Cancer Center
### 9:00 AM – 9:15 AM ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Neoadjuvant Combined Immunotherapy
9:00 AM – 9:15 AM ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Neoadjuvant Combined ImmunotherapyPresenter: – Memorial Sloan Kettering Cancer Center
Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center ### 1003985###Presenter###Chief, Gastrointestinal Oncology Service###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
###
9:15 AM – 9:30 AM ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Chemotherapy
9:15 AM – 9:30 AM ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - ChemotherapyPresenter: – Kansas University Cancer Center
Anup Kasi, MD, MPH – Kansas University Cancer Center ### 1919511###Presenter###Associate Professor###Kansas University Cancer Center###Presenter: – Kansas University Cancer Center
###
9:30 AM – 9:45 AM ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC)
9:30 AM – 9:45 AM ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - DiscussionModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – Kansas University Cancer Center
Panelist: – Memorial Sloan Kettering Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Anup Kasi, MD, MPH – Kansas University Cancer Center ### 1919511###Panelist###Associate Professor###Kansas University Cancer Center###Panelist: – Kansas University Cancer Center
### @@@ Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center ### 1003985###Panelist###Chief, Gastrointestinal Oncology Service###Memorial Sloan Kettering Cancer Center###Panelist: – Memorial Sloan Kettering Cancer Center
### 9:45 AM – 9:50 AM ET
Break
9:45 AM – 9:50 AM ET
Break
9:50 AM – 10:50 AM ET
Non-CME Innovation Theater (Sponsored By Merck)
9:50 AM – 10:50 AM ET
Non-CME Innovation Theater (Sponsored By Merck)
10:50 AM – 11:00 AM ET
Exhibit Hall
10:50 AM – 11:00 AM ET
Exhibit Hall
11:00 AM – 11:35 AM ET
3 - Session 3: Perspectives on Clinical Trial Development in Anal Cancer
11:00 AM – 11:35 AM ET
Session 3: Perspectives on Clinical Trial Development in Anal CancerPresenter: – Vanderbilt-Ingram Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Presenter###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Presenter: – Vanderbilt-Ingram Cancer Center
###
11:35 AM – 11:45 AM ET
3 - Session 3: Therapeutic Sequencing in Advanced Colorectal Cancer: New Strategies from Clinical Trial Data
11:35 AM – 11:45 AM ET
Live Q&APanelist: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Panelist###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Panelist: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### 11:45 AM – 12:20 PM ET
Session 4: Circulating Tumor DNA (ctDNA) in Gastrointestinal Malignancies
11:45 AM – 12:20 PM ET
Session 4: Circulating Tumor DNA (ctDNA) in Gastrointestinal MalignanciesPresenter: – Harvard Medical School; Massachusetts General Hospital
Aparna Parikh, MD, MS – Harvard Medical School; Massachusetts General Hospital ### 1422860###Presenter###Assistant Professor of Medicine; Medical Director, Center for Young Adult Colorectal Cancer###Harvard Medical School; Massachusetts General Hospital###Presenter: – Harvard Medical School; Massachusetts General Hospital
###
12:20 PM – 12:30 PM ET
Live Q&A
12:20 PM – 12:30 PM ET
Live Q&ASpeaker: – Harvard Medical School; Massachusetts General Hospital
Aparna Parikh, MD, MS – Harvard Medical School; Massachusetts General Hospital ### 1422860###Speaker###Assistant Professor of Medicine; Medical Director, Center for Young Adult Colorectal Cancer###Harvard Medical School; Massachusetts General Hospital###Speaker: – Harvard Medical School; Massachusetts General Hospital
### 12:30 PM – 12:35 PM ET
Break
12:30 PM – 12:35 PM ET
Break
12:35 PM – 1:35 PM ET
Non-CME Innvoation Theater (Sponsored By Astellas)
12:35 PM – 1:35 PM ET
Non-CME Innovation Theater (Sponsored By Astellas)
1:35 PM – 2:10 PM ET
Session 5: Advances in Neuroendocrine Tumors (NETs)
1:35 PM – 2:10 PM ET
Session 5: Advances in Neuroendocrine Tumors (NETs)Presenter: – The University of Texas MD Anderson Cancer Center
Arvind Dasari, MD – The University of Texas MD Anderson Cancer Center ### 1428669###Presenter###Associate Professor###The University of Texas MD Anderson Cancer Center###Presenter: – The University of Texas MD Anderson Cancer Center
###
2:10 PM – 2:20 PM ET
Live Q&A
2:10 PM – 2:20 PM ET
Live Q&APresenter: – The University of Texas MD Anderson Cancer Center
Arvind Dasari, MD – The University of Texas MD Anderson Cancer Center ### 1428669###Presenter###Associate Professor###The University of Texas MD Anderson Cancer Center###Presenter: – The University of Texas MD Anderson Cancer Center
### 2:20 PM – 2:55 PM ET
Session 6: Current and Emerging Therapies in Hepatocellular Carcinoma
2:20 PM – 2:55 PM ET
Session 6: Current and Emerging Therapies in Hepatocellular CarcinomaPresenter: – Department of Medicine, Memorial Sloan Kettering Cancer Center, Cornell University, New York; Weill Medical College, Cornell University, New York and Trinity College Dublin, Ireland
Ghassan K. Abou-Alfa, MD, MBA – Department of Medicine, Memorial Sloan Kettering Cancer Center, Cornell University, New York; Weill Medical College, Cornell University, New York and Trinity College Dublin, Ireland ### 697827###Presenter###Dr###Department of Medicine, Memorial Sloan Kettering Cancer Center, Cornell University, New York; Weill Medical College, Cornell University, New York and Trinity College Dublin, Ireland###Presenter: – Department of Medicine, Memorial Sloan Kettering Cancer Center, Cornell University, New York; Weill Medical College, Cornell University, New York and Trinity College Dublin, Ireland
###
2:55 PM – 3:05 PM ET
Live Q&A
2:55 PM – 3:05 PM ET
Live Q&ASpeaker: – Department of Medicine, Memorial Sloan Kettering Cancer Center, Cornell University, New York; Weill Medical College, Cornell University, New York and Trinity College Dublin, Ireland
Ghassan K. Abou-Alfa, MD, MBA – Department of Medicine, Memorial Sloan Kettering Cancer Center, Cornell University, New York; Weill Medical College, Cornell University, New York and Trinity College Dublin, Ireland ### 697827###Speaker###Dr###Department of Medicine, Memorial Sloan Kettering Cancer Center, Cornell University, New York; Weill Medical College, Cornell University, New York and Trinity College Dublin, Ireland###Speaker: – Department of Medicine, Memorial Sloan Kettering Cancer Center, Cornell University, New York; Weill Medical College, Cornell University, New York and Trinity College Dublin, Ireland
### 3:05 PM – 3:20 PM ET
Exhibit Hall
3:05 PM – 3:20 PM ET
Exhibit Hall
3:20 PM – 3:55 PM ET
6 - Session 7: Integration of Supportive Care
3:20 PM – 3:55 PM ET
Session 7: Integration of Supportive CarePresenter: – Memorial Sloan Kettering Cancer Center
Andrew Epstein, MD – Memorial Sloan Kettering Cancer Center ### 1880690###Presenter###Associate Attending ###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
###
3:55 PM – 4:05 PM ET
6 - Session 7: Integration of Supportive Care
3:55 PM – 4:05 PM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – Memorial Sloan Kettering Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Andrew Epstein, MD – Memorial Sloan Kettering Cancer Center ### 1880690###Panelist###Associate Attending ###Memorial Sloan Kettering Cancer Center###Panelist: – Memorial Sloan Kettering Cancer Center
### - Friday, September 29, 2023
8:00 AM – 8:15 AM ET
Welcome
8:00 AM – 8:15 AM ET
WelcomeCo-Chair: – Vanderbilt-Ingram Cancer Center
Co-Chair: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Co-Chair###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Co-Chair: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Co-Chair###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Co-Chair: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### 8:15 AM – 8:30 AM ET
8 - Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided All RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Triplet Chemo + Bevacizumab
8:15 AM – 8:30 AM ET
Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided All RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Triplet Chemo + BevacizumabPresenter: – Fox Chase Cancer Center
Namrata (Neena) Vijayvergia, MD, FACP – Fox Chase Cancer Center ### 1544845###Presenter###Assistant Chief, Gastrointestinal Medical Oncology; Associate Professor###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
###
8:30 AM – 8:45 AM ET
9 - Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided all RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Doublet Chemo + Panitumumab
8:30 AM – 8:45 AM ET
Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided all RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Doublet Chemo + PanitumumabPresenter: – Vanderbilt-Ingram Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Presenter###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Presenter: – Vanderbilt-Ingram Cancer Center
###
8:45 AM – 9:00 AM ET
9 - Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided all RAS Wild-Type Metastatic Colorectal Cancer (mCRC)
8:45 AM – 9:00 AM ET
Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided all RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - DiscussionModerator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – Vanderbilt-Ingram Cancer Center
Panelist: – Fox Chase Cancer Center
David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Panelist###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Panelist: – Vanderbilt-Ingram Cancer Center
### @@@ Namrata (Neena) Vijayvergia, MD, FACP – Fox Chase Cancer Center ### 1544845###Panelist###Assistant Chief, Gastrointestinal Medical Oncology; Associate Professor###Fox Chase Cancer Center###Panelist: – Fox Chase Cancer Center
### 9:00 AM – 9:35 AM ET
1 - Session 9: Emerging Treatment Strategies for HER2+ mCRC: Molecular Profiling and Targeted Therapies
9:00 AM – 9:35 AM ET
Session 9: Emerging Treatment Strategies for HER2+ mCRC: Molecular Profiling and Targeted TherapiesPresenter: – Duke University
John Strickler, MD (he/him/his) – Duke University ### 1422831###Presenter###Associate Professor###Duke University###Presenter: – Duke University
### he/him/his
9:35 AM – 9:45 AM ET
1 - Session 9: Emerging Treatment Strategies for HER2+ mCRC: Molecular Profiling and Targeted Therapies
9:35 AM – 9:45 AM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – Duke University
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ John Strickler, MD (he/him/his) – Duke University ### 1422831###Panelist###Associate Professor###Duke University###Panelist: – Duke University
### he/him/his9:45 AM – 9:50 AM ET
Break
9:45 AM – 9:50 AM ET
Break
9:50 AM – 10:50 AM ET
Non-CME Innvoation Theater (Sponsored By AstraZeneca)
9:50 AM – 10:50 AM ET
Non-CME Innovation Theater (Sponsored By AstraZeneca)
10:50 AM – 11:00 AM ET
Exhibit Hall
10:50 AM – 11:00 AM ET
Exhibit Hall
11:00 AM – 11:35 AM ET
18 - Session 10: Improving the Management of Cholangiocarcinoma: Adopting Recent NCCN Guidelines to Improve Patient Care in Diagnosis, Molecular Testing, and Targeted Treatment Strategies
11:00 AM – 11:35 AM ET
Session 10: Improving the Management of Cholangiocarcinoma: Adopting Recent NCCN Guidelines to Improve Patient Care in Diagnosis, Molecular Testing, and Targeted Treatment StrategiesPresenter: – MD Anderson Cancer Center, The University of Texas
Milind M. Javle, MD – MD Anderson Cancer Center, The University of Texas ### 944699###Presenter###Professor of Medicine###MD Anderson Cancer Center, The University of Texas###Presenter: – MD Anderson Cancer Center, The University of Texas
###
11:35 AM – 11:45 AM ET
18 - Session 10: Improving the Management of Cholangiocarcinoma: Adopting Recent NCCN Guidelines to Improve Patient Care in Diagnosis, Molecular Testing, and Targeted Treatment Strategies
11:35 AM – 11:45 AM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – MD Anderson Cancer Center, The University of Texas
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Milind M. Javle, MD – MD Anderson Cancer Center, The University of Texas ### 944699###Panelist###Professor of Medicine###MD Anderson Cancer Center, The University of Texas###Panelist: – MD Anderson Cancer Center, The University of Texas
### 11:45 AM – 12:20 PM ET
1 - Session 11: Integrating Biomarkers into the Management of Gastric Cancer: A Focus on Molecular Testing and Targeted Treatment Strategies
11:45 AM – 12:20 PM ET
Session 11: Integrating Biomarkers into the Management of Gastric Cancer: A Focus on Molecular Testing and Targeted Treatment StrategiesPresenter: – University of Wisconsin, Carbone Cancer Center
Nataliya Uboha, MD, PhD – University of Wisconsin, Carbone Cancer Center ### 904441###Presenter###Associate Professor###University of Wisconsin, Carbone Cancer Center###Presenter: – University of Wisconsin, Carbone Cancer Center
###
12:20 PM – 12:30 PM ET
1 - Session 11: Integrating Biomarkers into the Management of Gastric Cancer: A Focus on Molecular Testing
and Targeted Treatment Strategies
12:20 PM – 12:30 PM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – University of Wisconsin, Carbone Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Nataliya Uboha, MD, PhD – University of Wisconsin, Carbone Cancer Center ### 904441###Panelist###Associate Professor###University of Wisconsin, Carbone Cancer Center###Panelist: – University of Wisconsin, Carbone Cancer Center
### 12:30 PM – 12:35 PM ET
Break
12:30 PM – 12:35 PM ET
Break
12:35 PM – 1:35 PM ET
Non-CME Innvoation Theater (Sponsored By Exelixis)
12:35 PM – 1:35 PM ET
Non-CME Innovation Theater (Sponsored By Exelixis)
1:35 PM – 2:10 PM ET
Session 12: Therapeutic Sequencing in Advanced Colorectal Cancer: New Strategies from Clinical Trial Data
1:35 PM – 2:10 PM ET
Session 12: Therapeutic Sequencing in Advanced Colorectal Cancer: New Strategies from Clinical Trial DataPresenter: – Fox Chase Cancer Center
Namrata (Neena) Vijayvergia, MD, FACP – Fox Chase Cancer Center ### 1544845###Presenter###Assistant Chief, Gastrointestinal Medical Oncology; Associate Professor###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
###
2:10 PM – 2:20 PM ET
Live Q&A
2:10 PM – 2:20 PM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – Fox Chase Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Namrata (Neena) Vijayvergia, MD, FACP – Fox Chase Cancer Center ### 1544845###Panelist###Assistant Chief, Gastrointestinal Medical Oncology; Associate Professor###Fox Chase Cancer Center###Panelist: – Fox Chase Cancer Center
### 2:20 PM – 2:35 PM ET
15 - Session 13: Debate: Is There a Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - Yes
2:20 PM – 2:35 PM ET
Session 13: Debate: Is There a Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - YesPresenter: – Northwell Health Cancer Institute
Joseph Herman, MD, MSc, MHCM (he/him/his) – Northwell Health Cancer Institute ### 1849663###Presenter###Director of Clinical Research###Northwell Health Cancer Institute###Presenter: – Northwell Health Cancer Institute
### he/him/his
2:35 PM – 2:50 PM ET
15 - Session 13: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - No
2:35 PM – 2:50 PM ET
Session 13: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - NoPresenter: – Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Lisa Kachnic, MD (she/her/hers) – Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center ### 1849664###Presenter###Professor and Chair, Department of Radiation Oncology###Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center###Presenter: – Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
### she/her/hers
2:50 PM – 3:05 PM ET
15 - Session 13: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No
2:50 PM – 3:05 PM ET
Session 13: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - DiscussionModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – Northwell Health Cancer Institute
Panelist: – Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Joseph Herman, MD, MSc, MHCM (he/him/his) – Northwell Health Cancer Institute ### 1849663###Panelist###Director of Clinical Research###Northwell Health Cancer Institute###Panelist: – Northwell Health Cancer Institute
### he/him/his @@@ Lisa Kachnic, MD (she/her/hers) – Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center ### 1849664###Panelist###Professor and Chair, Department of Radiation Oncology###Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center###Panelist: – Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
### she/her/hers3:05 PM – 3:20 PM ET
Exhibit Hall
3:05 PM – 3:20 PM ET
Exhibit Hall
3:20 PM – 3:55 PM ET
15 - Session 14: The Pillars of Cancer Wellness
3:20 PM – 3:55 PM ET
Session 14: The Pillars of Cancer WellnessPresenter: – Memorial Sloan Kettering Cancer Center
Gary E. Deng, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1699641###Presenter###Medical Director, Integrative Medicine Service###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
###
3:55 PM – 4:05 PM ET
15 - Session 14: The Pillars of Cancer Wellness
3:55 PM – 4:05 PM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – Memorial Sloan Kettering Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Gary E. Deng, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1699641###Panelist###Medical Director, Integrative Medicine Service###Memorial Sloan Kettering Cancer Center###Panelist: – Memorial Sloan Kettering Cancer Center
### 4:05 PM – 4:20 PM ET
8 - Session 15: Debate: Pancreatic NETs: PRRT vs Chemotherapy - PRRT
4:05 PM – 4:20 PM ET
Session 15: Debate: Pancreatic NETs: PRRT vs Chemotherapy - PRRTPresenter: – The University of Texas MD Anderson Cancer Center
Arvind Dasari, MD – The University of Texas MD Anderson Cancer Center ### 1428669###Presenter###Associate Professor###The University of Texas MD Anderson Cancer Center###Presenter: – The University of Texas MD Anderson Cancer Center
###
4:20 PM – 4:35 PM ET
8 - Session 15: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Chemotherapy
4:20 PM – 4:35 PM ET
Session 15: Debate: Pancreatic NETs: PRRT vs Chemotherapy - ChemotherapyPresenter: – Fox Chase Cancer Center
Namrata (Neena) Vijayvergia, MD, FACP – Fox Chase Cancer Center ### 1544845###Presenter###Assistant Chief, Gastrointestinal Medical Oncology; Associate Professor###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
###
4:35 PM – 4:50 PM ET
8 - Session 15: Debate: Pancreatic NETs: PRRT vs Chemotherapy
4:35 PM – 4:50 PM ET
Session 15: Debate: Pancreatic NETs: PRRT vs Chemotherapy - DiscussionModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – The University of Texas MD Anderson Cancer Center
Panelist: – Fox Chase Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Arvind Dasari, MD – The University of Texas MD Anderson Cancer Center ### 1428669###Panelist###Associate Professor###The University of Texas MD Anderson Cancer Center###Panelist: – The University of Texas MD Anderson Cancer Center
### @@@ Namrata (Neena) Vijayvergia, MD, FACP – Fox Chase Cancer Center ### 1544845###Panelist###Assistant Chief, Gastrointestinal Medical Oncology; Associate Professor###Fox Chase Cancer Center###Panelist: – Fox Chase Cancer Center
### 4:50 PM – 5:25 PM ET
14 - Session 16: The Power of Patient Advocacy
4:50 PM – 5:25 PM ET
Session 16: The Power of Patient AdvocacyPresenter: – Fight Colorectal Cancer
Anjee Davis, MPPA (she/her/hers) – Fight Colorectal Cancer ### 1867780###Presenter###President###Fight Colorectal Cancer###Presenter: – Fight Colorectal Cancer
### she/her/hers
5:25 PM – 5:35 PM ET
14 - Session 16: The Power of Patient Advocacy
5:25 PM – 5:35 PM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – Fight Colorectal Cancer
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Anjee Davis, MPPA (she/her/hers) – Fight Colorectal Cancer ### 1867780###Panelist###President###Fight Colorectal Cancer###Panelist: – Fight Colorectal Cancer
### she/her/hers- Saturday, September 30, 2023
8:00 AM – 8:15 AM ET
Welcome
8:00 AM – 8:15 AM ET
WelcomeCo-Chair: – Vanderbilt-Ingram Cancer Center
Co-Chair: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Co-Chair###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Co-Chair: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Co-Chair###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Co-Chair: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### 8:15 AM – 8:50 AM ET
Session 17: Updates from Recent Meetings
8:15 AM – 8:50 AM ET
Session 17: Updates from Recent MeetingsPresenter: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Presenter###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Presenter: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### 8:50 AM – 9:00 AM ET
Session 17: Updates from Recent Meetings
8:50 AM – 9:00 AM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Panelist###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Panelist: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### 9:00 AM – 9:35 AM ET
Session 18: Novel Newer and Emerging Treatment Options for the Management of Non-MSI-H Metastatic Colorectal Cancer
9:00 AM – 9:35 AM ET
Session 18: Novel Newer and Emerging Treatment Options for the Management of Non-MSI-H Metastatic Colorectal CancerPresenter: – Vanderbilt-Ingram Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Presenter###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Presenter: – Vanderbilt-Ingram Cancer Center
### 9:35 AM – 9:45 AM ET
Session 17: Updates from Recent Meetings
9:35 AM – 9:45 AM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Ellery Altshuler ### 2125627###Invited Speaker#########Invited Speaker:
### 9:45 AM – 9:50 AM ET
Break
9:45 AM – 9:50 AM ET
Break
9:50 AM – 10:50 AM ET
Non-CME Innovation Theater (Sponsored By Taiho Oncology)
9:50 AM – 10:50 AM ET
Non-CME Innovation Theater (Sponsored By Taiho Oncology)
10:50 AM – 11:20 AM ET
Exhibit Hall
10:50 AM – 11:20 AM ET
Exhibit Hall
11:20 AM – 11:35 AM ET
21 - Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - FOLFIRINOX
11:20 AM – 11:35 AM ET
Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - FOLFIRINOXPresenter: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Presenter###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Presenter: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
###
11:35 AM – 11:50 AM ET
21 - Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - NALIRIFOX
11:35 AM – 11:50 AM ET
Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - NALIRIFOXPresenter: – MD Anderson Cancer Center, The University of Texas
Milind M. Javle, MD – MD Anderson Cancer Center, The University of Texas ### 944699###Presenter###Professor of Medicine###MD Anderson Cancer Center, The University of Texas###Presenter: – MD Anderson Cancer Center, The University of Texas
### 11:50 AM – 12:05 PM ET
21 - Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer
11:50 AM – 12:05 PM ET
Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - DiscussionModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: – MD Anderson Cancer Center, The University of Texas
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Panelist###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Panelist: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### @@@ Milind M. Javle, MD – MD Anderson Cancer Center, The University of Texas ### 944699###Panelist###Professor of Medicine###MD Anderson Cancer Center, The University of Texas###Panelist: – MD Anderson Cancer Center, The University of Texas
### 12:05 PM – 12:35 PM ET
Lunch
12:05 PM – 12:35 PM ET
Lunch
12:35 PM – 1:10 PM ET
19 - Session 20: Significance of Cancer Genetics
12:35 PM – 1:10 PM ET
Session 20: Significance of Cancer GeneticsPresenter: – University of Chicago
Sonia Kupfer, MD (she/her/hers) – University of Chicago ### 1849665###Presenter###Associate Professor of Medicine###University of Chicago###Presenter: – University of Chicago
### she/her/hers
1:10 PM – 1:20 PM ET
19 - Live Q&A
1:10 PM – 1:20 PM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Panelist: – University of Chicago
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Sonia Kupfer, MD (she/her/hers) – University of Chicago ### 1849665###Panelist###Associate Professor of Medicine###University of Chicago###Panelist: – University of Chicago
### she/her/hers1:20 PM – 1:55 PM ET
21 - Session 21: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and Gastric
1:20 PM – 1:55 PM ET
Session 21: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and GastricPresenter: – Vanderbilt-Ingram Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Presenter###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Presenter: – Vanderbilt-Ingram Cancer Center
###
1:55 PM – 2:05 PM ET
21 - Live Q&A
1:55 PM – 2:05 PM ET
Live Q&AModerator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
Presenter: – Vanderbilt-Ingram Cancer Center
David H. Ilson, MD, PhD – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center ### 693777###Moderator###Professor of Medicine, Attending Physician, Member###Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center###Moderator: – Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center
### @@@ Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Presenter###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Presenter: – Vanderbilt-Ingram Cancer Center
###
